FDA Inspection 1082231 — Taizhou Kangping Medical Science And Technology Co., Ltd.
The FDA completed an inspection of Taizhou Kangping Medical Science And Technology Co., Ltd. on March 7, 2019 in Taizhou. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- March 7, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Taizhou (China)